City page
Warsaw biotech and pharma directory
Warsaw is Poland's largest biotech and pharma cluster, anchored by major manufacturers Polpharma (one of Central Europe's largest pharma companies), Adamed (innovative + generic portfolio), and Bioton (insulin manufacturing). The capital concentrates commercial leadership, diagnostics, regulatory operations, and contract research — making it Poland's primary entry point for international partnerships and licensing. Warsaw University of Life Sciences (SGGW) and the Medical University of Warsaw anchor the academic-industrial coupling.
Where does this city read strongest?
CRO (3), Manufacturing (2), and Infrastructure anchor (2). Most visible records: BioResearch Pharma S.A., ExPLoRNA Therapeutics Sp. z o.o., and Genomed.
Which standards and public evidence are already visible?
GMP (4). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Warsaw.
By category
Warsaw by category
Jump into a category page filtered to this country only.
Full list
Warsaw biotech and pharma directory
13 city records currently match the active filter.
Current review cycle
BioResearch Pharma S.A.
WarsawPolandTherapeutics
Warsaw pharmaceutical R&D company focused on drug repositioning for dermatology, with programs in androgenetic alopecia and psoriasis and active BioInMed cluster membership.
- Lead
- Lukasz ZybaczynskiChief Executive Officer and Co-Founder
- Scale
- Drug-repositioning R&D
Current review cycle
ExPLoRNA Therapeutics Sp. z o.o.
WarsawPolandBiotech
Warsaw University spin-out developing novel mRNA cap-analog technology (AvantCap, ExploCap) for mRNA therapeutics, with Gates Foundation-funded programs.
- Lead
- Jacek JemielityChief Executive Officer and Co-Founder
- Scale
- mRNA chemistry R&D
Current review cycle
Genomed
WarsawPolandGenomics
Warsaw genomics and diagnostics company providing DNA and RNA sequencing, genetic testing, and molecular diagnostics from a long-running Polish genomics platform.
- Lead
- Anna Boguszewska-ChachulskaChief Executive Officer
- Scale
- Diagnostics and genomics services platform
Current review cycle
Scope Fluidics
WarsawPolandDiagnostics
Warsaw diagnostics and microfluidics company developing rapid antimicrobial-resistance and molecular-diagnostics platforms from a Polish innovation base.
- Lead
- Piotr GarsteckiPresident of the Management Board
- Scale
- Diagnostics platform
Current review cycle
Bioton
WarsawPolandManufacturing
Warsaw-headquartered insulin and biopharmaceutical manufacturer with major Polish production operations and a strong diabetes-therapeutics footprint.
- Lead
- Jeremy LaundersCEO and President of the Management Board
- Scale
- Commercial biomanufacturing footprint
Current review cycle
URPL Poland
WarsawPolandRegulatory anchor
Warsaw registration authority for medicinal products, medical devices, and biocidal products across the Polish pharmaceutical system.
- Lead
- Grzegorz CessakPresident
- Scale
- National registration authority
Current review cycle
Thermo Fisher Supply Warsaw
WarsawPolandInfrastructure anchor
Warsaw distribution node for medical-device and diagnostics storage, service, and trained technical support across Poland and the wider cluster.
- Lead
- Marc N. CasperChairman, President and Chief Executive Officer
- Scale
- Polish diagnostics and supply-distribution hub
Current review cycle
World Courier Poland
WarsawPolandInfrastructure anchor
Polish specialty-logistics node supporting clinical and commercial pharmaceutical shipments across the Baltic-German cluster.
- Lead
- Laurent BendavidPresident, World Courier
- Scale
- European specialty logistics network
Current review cycle
ICON Poland
WarsawPolandCRO
Warsaw clinical-research operations node connecting full-service CRO execution, trial management, and country-level delivery capacity in Poland.
- Lead
- Barry BalfeChief Executive Officer
- Scale
- Global CRO network with Poland execution node
Current review cycle
Medpace Poland
WarsawPolandCRO
Warsaw clinical-development and project-delivery node connecting Medpace's global CRO model into the Polish trial ecosystem.
- Lead
- August J. TroendleChief Executive Officer and Chairman
- Scale
- Global CRO network with Poland office node
Current review cycle
Pratia Poland
WarsawPolandCRO
Warsaw-centered research-site network node linking Polish investigator access, hybrid studies, and decentralized clinical-trial delivery.
- Lead
- Łukasz BęczkowskiChief Operating Officer
- Scale
- Multi-country site-network platform
Current review cycle
Molecure
WarsawPolandDrug discovery
Warsaw clinical-stage biotech platform developing first-in-class small-molecule programs across oncology and inflammatory-fibrotic disease.
- Lead
- Marcin Jan SzumowskiPresident of the Board and Chief Executive Officer
- Scale
- Clinical-stage drug discovery
Current review cycle
Polfa Tarchomin
WarsawPolandManufacturing
Warsaw pharmaceutical manufacturing node focused on finished dosage and hospital supply infrastructure inside Poland's legacy industrial base. The verified March 2026 record follows the current official management board disclosure rather than third-party or outdated references.
- Lead
- Maksymilian ŚwiniarskiChief Executive Officer and President of the Management Board
- Scale
- Commercial manufacturing
FAQ
Frequently asked questions
- What is the biggest biotech company in Warsaw?
- Polpharma is the largest pharma company headquartered in Warsaw — one of the biggest in Central and Eastern Europe by revenue, with manufacturing across Poland and a deep generic + specialty portfolio. Adamed and Bioton are the next largest Warsaw-headquartered operators. Several international pharma companies (Roche, Sanofi, Novartis) maintain Polish HQ in Warsaw.
- What sectors are strongest in Warsaw biotech?
- Warsaw is strongest in pharmaceutical manufacturing (Polpharma, Adamed, Bioton), insulin production (Bioton), generics + specialty pharma, clinical CRO services, regulatory affairs, and access to large clinical trial networks. The capital is the commercial center — Krakow handles more discovery-stage work.
- How does Warsaw compare to Krakow for biotech?
- Warsaw = commercial scale, manufacturing, and big pharma operations. Krakow = research-intensive discovery (Ryvu, Captor, Selvita) anchored by Jagiellonian University. They're complementary entry points: Warsaw for partnership and supply, Krakow for innovation pipeline and academic-industrial work.
Related briefs
Briefs that mention Warsaw
Polish Biotech & Pharma Landscape 2026: Warsaw, Wroclaw, Krakow
A practical map of the Polish biotech and pharma landscape in 2026 — Warsaw as pharma and regulatory anchor, Wroclaw as innovation belt, Krakow as discovery cluster, plus CDMO, clinical-research, and supply-chain layers — with 39 operators in the directory.
Open briefEuropean Pharma Cold Chain & GDP Logistics 2026: DHL, Kuehne+Nagel, World Courier
How European pharmaceutical cold chain and GDP-certified logistics actually work in 2026 — DHL Life Sciences & Healthcare (four German sites), Kuehne+Nagel Healthcare (Germany + Poland), World Courier (Germany + Baltics + Poland), and the Thermo Fisher + Avantor reagent supply layer.
Open briefEuropean Antibody & Biosimilar Therapeutics 2026: mAbs, ADCs, Biosimilars
A practical map of the European antibody + antibody-drug-conjugate + biosimilar therapeutics sector in 2026 — Genmab, ADC Therapeutics, Adcendo, Affimed, Tubulis, Heidelberg Pharma, Sandoz, Mabion, plus a Swedish + Swiss + Polish antibody innovator belt.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.